IRIS
MINISINI, Rosalba
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.131
EU - Europa 4.692
AS - Asia 2.931
SA - Sud America 445
Continente sconosciuto - Info sul continente non disponibili 224
AF - Africa 104
OC - Oceania 3
Totale 13.530
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.909
RU - Federazione Russa 1.144
SG - Singapore 951
IT - Italia 804
IE - Irlanda 755
CN - Cina 625
DE - Germania 504
HK - Hong Kong 374
VN - Vietnam 365
BR - Brasile 338
FR - Francia 322
SE - Svezia 321
UA - Ucraina 223
IN - India 191
GB - Regno Unito 148
FI - Finlandia 147
CA - Canada 115
BD - Bangladesh 101
CZ - Repubblica Ceca 94
KR - Corea 77
ID - Indonesia 57
AT - Austria 46
BJ - Benin 44
PL - Polonia 43
MX - Messico 40
TR - Turchia 40
AR - Argentina 39
NL - Olanda 34
ES - Italia 33
IQ - Iraq 24
JP - Giappone 22
ZA - Sudafrica 22
BE - Belgio 20
EC - Ecuador 18
IR - Iran 16
CO - Colombia 12
UZ - Uzbekistan 12
JM - Giamaica 11
LT - Lituania 11
TT - Trinidad e Tobago 11
VE - Venezuela 11
HN - Honduras 10
CL - Cile 9
PH - Filippine 9
CR - Costa Rica 8
EU - Europa 8
CH - Svizzera 7
EG - Egitto 7
PK - Pakistan 7
PY - Paraguay 7
SA - Arabia Saudita 7
GT - Guatemala 6
IL - Israele 6
MA - Marocco 6
PE - Perù 6
PT - Portogallo 6
TN - Tunisia 6
EE - Estonia 5
GP - Guadalupe 5
KE - Kenya 5
KZ - Kazakistan 5
MD - Moldavia 5
NI - Nicaragua 5
NP - Nepal 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
DZ - Algeria 4
UY - Uruguay 4
AU - Australia 3
AZ - Azerbaigian 3
BH - Bahrain 3
CW - ???statistics.table.value.countryCode.CW??? 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
JO - Giordania 3
MY - Malesia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
HR - Croazia 2
LB - Libano 2
LC - Santa Lucia 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
RO - Romania 2
SC - Seychelles 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
ET - Etiopia 1
GE - Georgia 1
GI - Gibilterra 1
Totale 13.306
Salva come PNG Salva come JPEG
Città #
Dublin 743
San Jose 643
Hong Kong 373
Jacksonville 371
Ashburn 348
Singapore 331
Council Bluffs 309
Beijing 188
Dearborn 182
Columbus 142
Novara 140
Los Angeles 139
Chandler 132
Moscow 130
Ho Chi Minh City 110
Milan 104
Piemonte 97
New York 94
Hanoi 93
Lauterbourg 92
Wilmington 87
Lawrence 81
Princeton 81
Munich 79
Buffalo 78
Santa Clara 72
Seoul 68
Ann Arbor 67
Turin 60
San Mateo 59
Phoenix 55
São Paulo 52
Cotonou 44
Dallas 43
Denver 42
Frankfurt am Main 41
Jakarta 41
Orem 39
Andover 38
Nuremberg 38
Vercelli 38
Brno 35
Brooklyn 35
Chicago 34
Pardubice 34
Warsaw 34
Helsinki 30
London 29
Chennai 28
Montreal 27
Boardman 26
Toronto 26
Atlanta 24
Falkenstein 24
Amsterdam 23
Houston 23
Bremen 21
Brussels 20
Nanjing 20
Tokyo 20
Vienna 20
Mexico City 19
Rome 19
Stockholm 19
Turku 19
Guangzhou 18
Poplar 18
Shanghai 18
The Dalles 18
Düsseldorf 16
Hillsboro 16
Brasília 15
Johannesburg 15
Seattle 15
Bologna 14
Mumbai 14
České Budějovice 14
Boston 13
North Bergen 13
Schaumburg 13
Philadelphia 12
Redondo Beach 12
Biên Hòa 11
San Francisco 11
Brescia 10
Charlotte 10
Dong Ket 10
Hefei 10
Marseille 10
Mülheim 10
Norwalk 10
Tashkent 10
Tianjin 10
Ankara 9
Cassano Magnago 9
Guayaquil 9
Haiphong 9
Jinan 9
Las Vegas 9
Miami 9
Totale 7.002
Salva come PNG Salva come JPEG
Nome #
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C 237
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis 210
Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 207
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort 198
Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis 197
rs1801253 Gly/Gly carriage in the ADRB1 gene leads to unbalanced cardiac sympathetic modulation as assessed by spectral analysis of heart rate variability 184
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial 180
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 177
Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease 174
Levosimendan inhibits peroxidation in hepatocytes by modulating apoptosis/autophagy interplay. 167
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 166
CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients 166
Gas6/TAM system: potential prognostic biomarker for Multiple Sclerosis 166
Treatment failure after interferon-free treatment of hepatitis C as a clue of a yet undetected hepatocellular carcinoma 166
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein 166
Antiviral treatment of hepatitis C improves glucose metabolism along the entire spectrum from normal glucose tolerance to diabetes 163
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 161
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort 160
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 160
Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients 159
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 152
Japanese encephalitis virus RNA detected in Culex pipiens mosquitoes in Italy 151
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 151
Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 151
L’impatto del Long COVID è stato minore nella terza ondata della pandemia rispetto alla prima ondata in una popolazione italiana di 324 pazienti. 149
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma 148
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 147
Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases 146
Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 144
Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs) 143
Gas6 as a putative noninvasive biomarker of hepatic fibrosis 142
Baseline plasma SARS-CoV-2 RNA detection predicts an adverse COVID-19 evolution in moderate to severe hospitalized patients 141
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 141
Understanding protection from SARS-CoV-2 using metabolomics 138
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 138
Gas6/TAM system as potential biomarker for multiple sclerosis prognosis 137
17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle 137
Lower Circulating Gas6 Levels Are Associated with Bulbar Phenotype and Faster Disease Progression in Amyotrophic Lateral Sclerosis Patients 136
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 135
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 132
Influence of age on sex-related differences among patients with hepatitis C. 130
Risk of hepatocellular carcinoma and death among cirrhotics who carry genetic variants of epidermal growth factor, Adiponutrin and 17β-Hydroxysteroid Dehydrogenase-13: a long-term cohort study 126
COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters 126
APOLIPOPROTEIN E GENOTYPES MODULATE FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES 125
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease 125
Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment 124
Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease 123
Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of the AST to platelet ratio index 123
Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C 123
ACE genotype, body weight changes and target organ damage in renal transplant recipients 123
Circadian control of hepatitis B virus replication 122
Recent advances in HCV entry 121
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 121
Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis 119
Severity of nonalcoholic fatty liver disease in type 2 diabetes mellitus: Relationship between nongenetic factors and PNPLA3/HSD17B13 polymorphisms 118
IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients. 117
Carriage of the apolipoprotein E-epsilon4 allele and histologic outcome of recurrent hepatitis C after antiviral treatment 117
Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells 116
Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter? 115
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma 112
Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis C 112
Can apical ballooning cardiomyopathy and anterior STEMI be differentiated based on β1 and β2-adrenergic receptors polymorphisms? 112
Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study. 111
HBV AND LYMPHOMAGENESIS: NOVEL INSIGHTS INTO AN OCCULT RELATIONSHIP 110
Low fibrosis progression of recurrent hepatitis C in apolipoprotein E epsilon4 carriers: relationship with the blood lipid profile 109
Elevated Plasma Levels of Growth Arrest Specific 6 (Gas6) Protein in Severe Obesity: Implications for Adipose Tissue and Inflammation 109
Interferon-stimulated gene pathways in the treatment of viral hepatitis 107
Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C. 106
Modulation of Oxidative Stress by 17 β-Estradiol and Genistein in Human Hepatic Cell Lines In Vitro 106
Hepatitis B virus and lymphomagenesis: novel insights into an occult relationship 105
Combinatorial use of single nucleotide polymorphisms to help predict liver fibrosis in patients with hepatitis C infections 104
Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study 104
Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C 103
Reference values of one-point carotid stiffness parameters determined by carotid echo-tracking and brachial pulse pressure in a large population of healthy subjects 103
T-cell mediated responses against alpha-foetoprotein in hepatocellular carcinoma: Relationship with hepatitis C virus infection, tumour phenotype and patients’ survival 103
Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome 102
INTERLEUKIN 6 PROMOTER POLYMORPHISMS INFLUENCE THE OUTCOME OF CHRONIC HEPATITIS C 101
Robust and persistent b-and t-cell responses after covid-19 in immunocompetent and solid organ transplant recipient patients 100
Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma 97
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 95
Evaluation of donor hepatic iron concentration as a factor of early fibrotic progression after liver transplantation 94
Impact of Age and Sex on Viral Load in Hepatitis C Virus Infection 93
Inflammatory and Immune Responses during SARS-CoV-2 Infection in Vaccinated and Non-Vaccinated Pregnant Women and Their Newborns 92
GENETIC POLYMORPHISM AT THE APOLIPOPROTEIN E LOCUS AFFECTS THE OUTCOME OF CHRONIC HEPATITIS B 92
Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation 92
Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C 91
Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation 91
Unsuspected strongyloidiasis in hospitalized elderly patients with and without eosinophilia 89
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development 89
TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer 88
Role of Interleukin 28B rs12979860 C/T Polymorphism on the Histological Outcome of Chronic Hepatitis C: Relationship with Gender and Viral Genotype 88
From MASH to HCC: the role of Gas6/TAM receptors 87
Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation 87
Prevalence and clinical relevance of occult hepatitis B virus infection in patients on the waiting list for kidney transplantation 84
Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation 83
IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC 82
MTHFR C677T Polymorphism and Risk of HCC in Patients With Liver Cirrhosis: Role of Male Gender and Alcohol Consumption 80
Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression 80
Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C 79
Pegylated Vs. conventional interferon–alpha in antiviral regimens for recurrent hepatitis C: a comparison of tolerability and efficacy 77
Totale 12.686
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.670
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.670
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022421 0 0 0 39 29 0 46 19 43 40 81 124
2022/20231.513 153 74 84 16 69 116 59 52 762 13 81 34
2023/2024919 54 108 51 25 152 39 186 29 23 43 68 141
2024/20251.687 41 30 91 33 55 91 188 164 341 120 153 380
2025/20265.618 265 215 301 750 607 354 853 900 410 443 323 197
2026/20271.490 213 401 457 419 0 0 0 0 0 0 0 0
Totale 13.530